The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology

Keyphrases

• Neuroblastoma 100%
• Pediatric Oncology 100%
• Novel Therapeutics 100%
• Immune Landscape 100%
• Tumor-infiltrating Lymphocytes 60%
• High-risk Neuroblastoma 40%
• Immune Defense 40%
• Adult Cancer 20%
• Pediatric Cancer 20%
• Standard of Care 20%
• Mutational Load 20%
• Neuroblastoma Tumor 20%
• Immune Cells 20%
• Prognostic Value 20%
• T Cells 20%
• Natural Killer Cells 20%
• Antibody Therapy 20%
• Dinutuximab 20%
• 5-year Survival 20%
• Infiltration 20%
• Anti-GD2 Antibody 20%
• Adoptive Cell Therapy 20%
• Stromal Cells 20%
• Tumor Immunology 20%
• Immunomodulatory 20%
• Immune Checkpoint Molecules 20%
• Small Fraction 20%
• Tumor Reactivity 20%
• Immunotherapeutic Approaches 20%
• Tumor Immune Evasion 20%
• Immune Checkpoint Blockade Antibodies 20%
• Successful Implementation 20%
• Improved Patient Outcomes 20%
• Tumor Infiltration 20%
• Personalization Strategy 20%
• Low Immunogenicity 20%
• Composition Function 20%
• Immunosuppressive Myeloid Cells 20%
• Value Function 20%
• Artistic Development 20%
• Immunotherapy Strategies 20%
• Immunotherapeutic Interventions 20%
• MHC-I Expression 20%
• T-cell Engaging Therapies 20%

Immunology and Microbiology

• Immunotherapy 100%
• Immune Landscape 100%
• Tumor-Infiltrating Lymphocytes 75%
• T Cell 50%
• Immune Evasion 25%
• Mutational Load 25%
• Natural Killer Cell 25%
• Myeloid 25%
• Secretion (Process) 25%
• Mediator 25%
• Immunocompetent Cell 25%
• Survival Rate 25%
• Immunogenicity 25%
• Dinutuximab 25%
• Immunosuppressive Drug 25%
• Immune Checkpoint Blockade 25%
• Tumor Immunology 25%
• Tumor Escape 25%
• Adoptive T Cell Therapy 25%

Medicine and Dentistry

• Ganglioneuroblastoma 100%
• Childhood Cancer 100%
• Immunotherapy 50%
• T Cell 37%
• Tumor 37%
• Tumor Infiltrating Lymphocyte 37%
• Pediatric Cancer 12%
• Cancer 12%
• Survival Rate 12%
• Immunocompetent Cell 12%
• Cell Therapy 12%
• Myeloid Cell 12%
• Natural Killer Cell 12%
• Mediator 12%
• Dinutuximab 12%
• Mutational Load 12%
• Secretion (Process) 12%
• Immune Checkpoint Blockade 12%
• Immunogenicity 12%
• Stromal Cell 12%
• Tumor Escape 12%
• Tumor Immunology 12%
• Immunosuppressive Drug 12%
• Immune Evasion 12%